13F Data
13F filer · CIK 78003

Pfizer Inc

New York, NY · filing since Q4 2024 · last filing Aug 13, 2026
Reported value
$170.4M
$-68.4M vs prior
Positions
17
New / sold out
0 / 1
Added / reduced
0 / 3
Turnover
0.0%
buys $0 · sells $55.2M
Top-10 weight
95.8%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedORIC PHARMACEUTICALS INC-4,407,497-92.2%$-42.0M
ReducedZURA BIO LTD-2,300,072-81.0%$-12.3M
Sold outQ32 BIO INC-101,618-100.0%$-736.7K
ReducedNEXTCURE INC-109,007-71.1%$-179.4K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $2.6BQ1 2025: $500.8MQ2 2025: $576.2MQ3 2025: $437.5MQ4 2025: $236.5MQ1 2026: $238.8MQ2 2026: $170.4M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ALLOGENE THERAPEUTICS INCCOM22,032,040$46.9M27.55%
2CELCUITY INCCOM295,652$29.6M17.35%
3ARVINAS INCCOM3,457,815$27.7M16.24%
4PYXIS ONCOLOGY INCCOMMON STOCK7,032,770$19.5M11.43%
5WAVE LIFE SCIENCES LTDSHS1,875,000$10.9M6.42%
6BIOHAVEN LTDCOM505,645$8.0M4.70%
7CARIBOU BIOSCIENCES INCCOM4,690,431$7.9M4.63%
8SPERO THERAPEUTICS INCCOM2,362,348$5.3M3.13%
9ZENTALIS PHARMACEUTICALS INCCOM953,834$3.9M2.26%
10ORIC PHARMACEUTICALS INCCOM372,904$3.6M2.09%
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.